The site of the Media Sphera Publishers contains materials intended solely for healthcare professionals.
By closing this message, you confirm that you are a certified medical professional or a student of a medical educational institution.

A.N. Boyko

Pirogov Russian National Research Medical University;
Federal Center of Brain Research and Neurotechnologies of the Federal Medical Biological Agency

K.Z. Bakhtiyarova

Bashkir State Medical University

O.V. Boyko

Federal Center for Brain Research and Neurotechnology

V.A. Dudin

Center for Cardiology and Neurology»

L.G. Zaslavsky

Pavlov First Saint Petersburg State Medical University

N.A. Malkova

State Novosibirsk Regional Clinical Hospital;
Novosibirsk State Medical University

E.V. Parshina

Semashko Nizhny Novgorod Regional Clinical Hospital

I.Ye. Poverennova

Seredavin Samara Regional Clinical Hospital

S.A. Sivertseva

Medical and Sanitary unit «Neftyanik»

N.A. Totolyan

Academician I.P. Pavlov First Saint Petersburg State Medical University

S.G. Shchur

Municipal Filatov Clinical Hospital No. 15

F.A. Khabirov

City Clinical Hospital No. 7;
Kazan State Medical Academy — Branch of the Russian Medical Academy of Continuing Professional Education

Z.A. Goncharova

Rostov State Medical University

M.N. Zakharova

Research Center of Neurology

D.D. Bolsun

AO BIOCAD

A.V. Zinkina-Orikhan

AO BIOCAD

Yu.N. Linkova

AO BIOCAD

T.V. Chernovskaya

JSC «BIOCAD»

A.A. Porozova

JSC «BIOCAD»

Long-term Efficacy and Safety of Sampeginterferon-β1a in the Treatment of Relapsing Remitting Multiple Sclerosis: a Randomized, Double-Blind Clinical Trial 104-Week Results

Authors:

A.N. Boyko, K.Z. Bakhtiyarova, O.V. Boyko, V.A. Dudin, L.G. Zaslavsky, N.A. Malkova, E.V. Parshina, I.Ye. Poverennova, S.A. Sivertseva, N.A. Totolyan, S.G. Shchur, F.A. Khabirov, Z.A. Goncharova, M.N. Zakharova, D.D. Bolsun, A.V. Zinkina-Orikhan, Yu.N. Linkova, T.V. Chernovskaya, A.A. Porozova

More about the authors

Views: 1228

Downloaded: 5


To cite this article:

Boyko AN, Bakhtiyarova KZ, Boyko OV, Dudin VA, Zaslavsky LG, Malkova NA, Parshina EV, Poverennova IYe, Sivertseva SA, Totolyan NA, Shchur SG, Khabirov FA, Goncharova ZA, Zakharova MN, Bolsun DD, Zinkina-Orikhan AV, Linkova YuN, Chernovskaya TV, Porozova AA. Long-term Efficacy and Safety of Sampeginterferon-β1a in the Treatment of Relapsing Remitting Multiple Sclerosis: a Randomized, Double-Blind Clinical Trial 104-Week Results. Zhurnal Nevrologii i Psikhiatrii imeni S.S. Korsakova. 2023;123(2):52‑59. (In Russ.)
https://doi.org/10.17116/jnevro202312302152

Recommended articles:
A clinical case of multiple scle­rosis with an episode of schi­zophrenia-like syndrome. Zhurnal Nevrologii i Psikhiatrii imeni S.S. Korsakova. 2023;(4):120-124
BDNF gene RS6265 poly­morphism in patients with multiple scle­rosis of Tomsk region. Zhurnal Nevrologii i Psikhiatrii imeni S.S. Korsakova. 2023;(5):160-164
New neuroimaging methods in asse­ssing the acti­vity of neuroinflammation in multiple scle­rosis. Zhurnal Nevrologii i Psikhiatrii imeni S.S. Korsakova. 2023;(7-2):8-14
Changes in venous circulation in patients with multiple scle­rosis. Zhurnal Nevrologii i Psikhiatrii imeni S.S. Korsakova. 2023;(7-2):22-28
Rela­tionship of patients with multiple scle­rosis to vaccination against COVID-19. Zhurnal Nevrologii i Psikhiatrii imeni S.S. Korsakova. 2023;(7-2):29-33

Email Confirmation

An email was sent to test@gmail.com with a confirmation link. Follow the link from the letter to complete the registration on the site.

Email Confirmation



We use cооkies to improve the performance of the site. By staying on our site, you agree to the terms of use of cооkies. To view our Privacy and Cookie Policy, please. click here.